Characteristics and risk factors of bortezomib induced peripheral neuropathy: A systematic review of phase III trials

硼替佐米 周围神经病变 医学 外围设备 相(物质) 内科学 肿瘤科 多发性骨髓瘤 内分泌学 物理 量子力学 糖尿病
作者
Tiffany Li,Hannah C. Timmins,Tracy King,Matthew C. Kiernan,David Goldstein,Susanna B. Park
出处
期刊:Hematological Oncology [Wiley]
卷期号:38 (3): 229-243 被引量:36
标识
DOI:10.1002/hon.2706
摘要

Bortezomib-induced peripheral neuropathy (BIPN) is a common toxicity associated with the treatment of multiple myeloma (MM), typically requiring dose reduction, delay, or cessation of treatment protocol. This systematic review aimed to investigate risk factors, trends, and variability associated with the development of BIPN. Searches were undertaken using Medline, PubMed, Cochrane Central Register of Controlled Trials, Embase, Scopus, and Web of Science. Additional studies were identified by investigating authors' bibliographic references cited by original and review articles. Articles that reported on neuropathy in phase III randomised control trials involving bortezomib in any treatment arm for the treatment of MM were included in this review. A total of 43 full text articles met criteria, which examined 23 phase III trials (N = 8218). Overall incidence of neuropathy ranged from 8.4% to 80.5% (median = 37.8%) and severe neuropathy (grade 3-4) ranged from 1% to 33.2% (median = 8%). Similar reports of neuropathy of any grade and severe neuropathy were observed between the newly diagnosed and relapsed cohort. Bortezomib regimens with reduced dose intensity were associated with reduced neuropathy incidence. Increased cumulative dosing levels, intravenous compared with subcutaneous administration and combination therapy with thalidomide were associated with higher rates of BIPN. This analysis revealed that BIPN is a significant toxicity. More sensitive measures are required to capture the incidence and severity of BIPN. Better understanding of risk factors and reversibility profiles will minimise the number of cancer survivors living with residual treatment side effects.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
南风吹梦完成签到,获得积分10
1秒前
4秒前
强仔爱写文章完成签到,获得积分20
5秒前
6秒前
正直远望发布了新的文献求助10
9秒前
elisa2023发布了新的文献求助10
9秒前
Kun发布了新的文献求助10
11秒前
江屿完成签到,获得积分10
12秒前
12秒前
yliaoyou完成签到,获得积分10
16秒前
康谨发布了新的文献求助10
17秒前
小红关注了科研通微信公众号
18秒前
细雨带风吹完成签到,获得积分10
19秒前
19秒前
敏感晓啸发布了新的文献求助10
22秒前
Jessica完成签到,获得积分10
22秒前
Kun发布了新的文献求助30
26秒前
大模型应助强仔爱写文章采纳,获得10
28秒前
29秒前
29秒前
羊羊羊完成签到,获得积分10
32秒前
wwd完成签到,获得积分10
34秒前
34秒前
wangbq发布了新的文献求助20
34秒前
上官若男应助ycd采纳,获得20
39秒前
矢车菊完成签到 ,获得积分10
40秒前
可罗雀完成签到,获得积分10
44秒前
微笑可乐完成签到,获得积分10
47秒前
无花果应助kiki采纳,获得10
48秒前
vovoking完成签到 ,获得积分10
50秒前
Pawn完成签到,获得积分10
54秒前
Kun发布了新的文献求助50
54秒前
56秒前
无情耷完成签到,获得积分10
57秒前
云母完成签到 ,获得积分10
58秒前
1分钟前
李春霞发布了新的文献求助10
1分钟前
正直远望完成签到,获得积分10
1分钟前
完美世界应助MILK采纳,获得10
1分钟前
Kun发布了新的文献求助10
1分钟前
高分求助中
【此为提示信息,请勿应助】请按要求发布求助,避免被关 20000
Encyclopedia of Geology (2nd Edition) 2000
Периодизация спортивной тренировки. Общая теория и её практическое применение 310
Mixing the elements of mass customisation 300
the MD Anderson Surgical Oncology Manual, Seventh Edition 300
Nucleophilic substitution in azasydnone-modified dinitroanisoles 300
Platinum-group elements : mineralogy, geology, recovery 260
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3780394
求助须知:如何正确求助?哪些是违规求助? 3325736
关于积分的说明 10224182
捐赠科研通 3040851
什么是DOI,文献DOI怎么找? 1669087
邀请新用户注册赠送积分活动 799013
科研通“疑难数据库(出版商)”最低求助积分说明 758649